HLA-DR,DQ and APOE genotypes and gender influence in Sardinian primary progressive MS

被引:25
作者
Cocco, E
Sotgiu, A
Costa, G
Murru, MR
Mancosu, C
Murru, R
Lai, M
Contu, P
Marrosu, MG
机构
[1] Osped Binaghi, Ctr Sclerosi Multipla, Dipartimento Neurosci, I-09126 Cagliari, Italy
[2] Osped Binaghi, Ctr Sclerosi Multipla, Dipartimento Salute Pubblica, I-09126 Cagliari, Italy
关键词
D O I
10.1212/01.WNL.0000150579.54878.00
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
The authors examined the influence of APOE and human leukocyte antigen-DRB1-DQB1 polymorphisms on the course of multiple sclerosis in 871 patients, 773 with relapsing and 98 with primary progressive disease, and 348 control subjects. The risk of the primary progressive course was increased (odds ratio = 6.81, p = 0.002) in women carrying the APOE4 but not the DRB1-DQB1 predisposing genotype, suggesting in this subgroup of patients a reciprocal influence between these genes and gender in modulating clinical variability of the disease.
引用
收藏
页码:564 / 566
页数:3
相关论文
共 10 条
[1]
APOE genotype is a major predictor of long-term progression of disability in MS [J].
Chapman, J ;
Vinokurov, S ;
Achiron, A ;
Karussis, DM ;
Mitosek-Szewczyk, K ;
Birnbaum, M ;
Michaelson, DM ;
Korczyn, AD .
NEUROLOGY, 2001, 56 (03) :312-316
[2]
Apolipoprotein Eε4 is associated with rapid progression of multiple sclerosis [J].
Fazekas, F ;
Strasser-Fuchs, S ;
Kollegger, H ;
Berger, T ;
Kristoferitsch, W ;
Schmidt, H ;
Enzinger, C ;
Schiefermeier, M ;
Schwarz, C ;
Kornek, B ;
Reindl, M ;
Huber, K ;
Grass, R ;
Wimmer, G ;
Vass, K ;
Pfeiffer, KH ;
Hartung, HP ;
Schmidt, R .
NEUROLOGY, 2001, 57 (05) :853-857
[3]
HIXSON JE, 1990, J LIPID RES, V31, P545
[4]
Association of APOE polymorphisms with disease severity in MS is limited to women [J].
Kantarci, OH ;
Hebrink, DD ;
Achenbach, SJ ;
Pittock, SJ ;
Altintas, A ;
Schaefer-Klein, JL ;
Atkinson, EJ ;
de Andrade, M ;
McMurray, CT ;
Rodriguez, M ;
Weinshenker, BG .
NEUROLOGY, 2004, 62 (05) :811-814
[5]
Brain region-specific up-regulation of mouse apolipoprotein E by pharmacological estrogen treatments [J].
Levin-Allerhand, J ;
McEwen, BS ;
Lominska, CE ;
Lubahn, DB ;
Korach, KS ;
Smith, JD .
JOURNAL OF NEUROCHEMISTRY, 2001, 79 (04) :796-803
[6]
Defining the clinical course of multiple sclerosis: Results of an international survey [J].
Lublin, FD ;
Reingold, SC .
NEUROLOGY, 1996, 46 (04) :907-911
[7]
APOE genotype and an ApoE-mimetic peptide modify the systemic and central nervous system inflammatory response [J].
Lynch, JR ;
Tang, W ;
Wang, HC ;
Vitek, MP ;
Bennett, ER ;
Sullivan, PM ;
Warner, DS ;
Laskowitz, DT .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (49) :48529-48533
[8]
Dissection of the HLA association with multiple sclerosis in the founder isolated population of Sardinia [J].
Marrosu, MG ;
Murru, R ;
Murru, MR ;
Costa, G ;
Zavattari, P ;
Whalen, M ;
Cocco, E ;
Mancosu, C ;
Schirru, L ;
Solla, E ;
Fadda, E ;
Melis, C ;
Porru, I ;
Rolesu, M ;
Cucca, F .
HUMAN MOLECULAR GENETICS, 2001, 10 (25) :2907-2916
[9]
Androgens are protective in experimental autoimmune encephalomyelitis: implications for multiple sclerosis [J].
Palaszynski, KM ;
Loo, KK ;
Ashouri, JF ;
Liu, HB ;
Voskuhl, RR .
JOURNAL OF NEUROIMMUNOLOGY, 2004, 146 (1-2) :144-152
[10]
Thompson AJ, 2000, ANN NEUROL, V47, P831